Peter E. Lonergan

University of California, San Francisco

Papers

2

Total Citations

23

H-Index

2

About

Dr. Peter E. Lonergan is a urologic surgeon and researcher whose work centers on improving surgical outcomes for prostate cancer patients, with a particular focus on the intersection of operative technique and postoperative quality of life. His most cited study, published in 2022, investigated the role of preoperative membranous urethral length in predicting urinary incontinence following robot-assisted radical prostatectomy—a finding that has direct implications for patient counseling and surgical planning, earning 17 citations. Dr. Lonergan has also made important contributions to our understanding of biochemical recurrence after prostate removal. His 2021 study challenged conventional assumptions by demonstrating that residual benign prostate glandular tissue at the surgical margin is not associated with detectable postoperative PSA or biochemical recurrence. This work helps refine the interpretation of post-prostatectomy PSA levels, potentially sparing patients unnecessary anxiety or additional treatment. By combining rigorous methodology with clinically relevant questions, Dr. Lonergan’s research bridges the gap between surgical precision and patient-centered outcomes, making him a valuable voice in the ongoing effort to optimize recovery and oncologic control for men with prostate cancer.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago